Literature DB >> 17440948

Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci.

Gillian Hamilton1, Petra Proitsi, Luke Jehu, Angharad Morgan, Julie Williams, Michael C O'Donovan, Michael J Owen, John F Powell, Simon Lovestone.   

Abstract

Epidemiological evidence supports the existence of a possible link between type II diabetes mellitus (T2DM) and late-onset Alzheimer's disease (LOAD). Polymorphisms from candidate genes for T2DM were genotyped in a two-stage approach to identify novel risk factors for LOAD. One hundred fifty-two polymorphisms were initially genotyped in a case:control cohort: nine SNPs showed individual association with disease status under at least one genetic model, while an additional two SNPs showed a haplotype association. In a replication study, we confirmed significant association of SNPs within three genes--PPARgamma, SOS2, and PCK1--with Alzheimer's disease. In particular, our data suggest that the effect of variants within these genes might be influenced by gender. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440948     DOI: 10.1002/ajmg.b.30503

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  22 in total

1.  The relationship of diet and acne: A review.

Authors:  Apostolos Pappas
Journal:  Dermatoendocrinol       Date:  2009-09

Review 2.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

3.  Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.

Authors:  Rupinder K Sodhi; Nirmal Singh; Amteshwar S Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-24       Impact factor: 3.000

5.  Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.

Authors:  S Wang; L Guan; D Luo; J Liu; H Lin; X Li; X Liu
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

6.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

7.  Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

Authors:  Joshua M Shulman; Lori B Chibnik; Cristin Aubin; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.

Authors:  Nancy A West; Jonathan V Tingle; Jeannette Simino; Elizabeth Selvin; Jan Bressler; Thomas H Mosley
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Apr-Jun       Impact factor: 2.703

Review 9.  PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.

Authors:  Gary Landreth; Qingguang Jiang; Shweta Mandrekar; Michael Heneka
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

10.  Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.

Authors:  Richard Killick; Georgie Scales; Karelle Leroy; Mirsada Causevic; Claudie Hooper; Elaine E Irvine; Agharul I Choudhury; Laura Drinkwater; Fiona Kerr; Hind Al-Qassab; John Stephenson; Zehra Yilmaz; K Peter Giese; Jean-Pierre Brion; Dominic J Withers; Simon Lovestone
Journal:  Biochem Biophys Res Commun       Date:  2009-06-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.